Winton Group’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27K Buy
+11,600
New +$35.1K ﹤0.01% 1089

Other funds holding PYXS

Winton Group's PYXS Position: Q3 2026 in Review

Winton Group opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 11,600 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #1089 among its holdings.

101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Winton Group held 11,600 shares of Pyxis Oncology worth $27K as of Q3 2026.
  • Pyxis Oncology was a new Winton Group position in Q3 2026.
  • Pyxis Oncology made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1089 holding.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.